Recent Winners On GuerillaStockTrading


+87%
ARIA
Alert Price: $12.72
High Price: $23.75
Results: 87% in 20 Days
+32%
EBS
Alert Price: $27.22
High Price: $35.88
Results: 32% in 6 Days
+23%
CNAT
Alert Price: $4.43
High Price: $5.45
Results: 23% in 3 Days
+23%
PEIX
Alert Price: $8.30
High Price: $10.25
Results: 23% in 12 Days
+21%
KATE
Alert Price: $15.40
High Price: $18.67
Results: 21% in 11 Days
+20%
REPH
Alert Price: $6.89
High Price: $8.25
Results: 20% in 11 Days
+15%
PVG
Alert Price: $7.17
High Price: $8.24
Results: 15% in 6 Days
+12%
OCLR
Alert Price: $8.49
High Price: $9.55
Results: 12% in 7 Days
+12%
ACET
Alert Price: $19.50
High Price: $21.93
Results: 12% in 26 Days
+12%
COW
Alert Price: $20.00
High Price: $22.42
Results: 12% in 26 Days
+10%
HWKN
Alert Price: $48.15
High Price: $52.90
Results: 10% in 14 Days
+9%
LLY
Alert Price: $67.61
High Price: $73.56
Results: 9% in 12 Days
+4%
WLH
Alert Price: $19.94
High Price: $20.75
Results: 4% in 13 Days
+4%
AMAT
Alert Price: $31.53
High Price: $32.69
Results: 4% in 9 Days
+4%
TAST
Alert Price: $14.05
High Price: $14.55
Results: 4% in 21 Days

Past results are not indicative of future profits. This table is accurate, though not every trade is represented.

Top Catalysts For The Week Ending January 20 2017


Sanchez Energy = Eagleford Acquisition Doubles Drilling Inventory

Mobileye = Goldman Sachs Raised Mobileye To A Buy Rating

Tesla = Expanding Investment In Gigafactory by $350 Million, Adding 550 New Jobs To Make Model 3

AbbVie = Gets FDA Approval For Imbruvica

3D Systems = Hearing Takeover Rumors Circulating About GE

International Game Technology = Wins Big Contract From Svenska Spel in Sweden

WiLAN = Court of Appeals Grants WiLAN Positive Rulings In Case Against Ericsson

Gilead Sciences = Hearing Takeover Rumors Circulating

Juno = Hearing Juno Takeover Rumors Circulating

Fusion Telecommunications = Awarded 3-year $100K For Managed Cloud Services

Teva Pharmaceutical = Receives FDA Approval For Vantrela ER

EPAM Systems = Lands Giant UBS Multi-year Agreement Valued At Over $300 Million

Tutor Perini Building = Receives Notice of Intent To Award a $1.37 Billion Contract From Los Angeles County

Amicus Therapeutics = Hearing Takeover Rumors Circulating

CEMEX = Trump Build That Wall Play

Iridium Communications = Announces Successful First Launch For Space-Based ADS-B Network

Applied Optoelectronics = Play On Switch From Copper To Optical Interconnect Inside Datacenters

3D Systems = Expands its Virtual Surgical Planning Service to Include Cranial Applications

Trading Lessons

Mainstream Financial News

Archives

Institutional Traders Buying Eleven Biotherapeutics

Follow Us on StockTwits

January 7, 2017: According to 13F filings, institutional traders are accumulating Eleven Biotherapeutics. Firms that bought shares according to their most recent 13F filings are: Flagship Ventures Management, Blackrock Institutional Trust, VANGUARD GROUP, MILLENNIUM MANAGEMENT, Bank of New York Mellon, Dynamic Technology, SUSQUEHANNA INTERNATIONAL, KCG Holdings, PRICE T ROWE, and many more.

Revenue YOY is up an incredible 42,661.19%.

Eleven Biotherapeutics Stock Chart

Eleven Biotherapeutics, Inc. is a late clinical-stage company advancing a broad pipeline of anti-cancer agents based on Targeted Protein Therapeutics (TPTs) platform. Our TPTs genetically combine targeting antibody fragments with cytoxic protein payloads to create a single fusion protein through Eleven’s proprietary one-step manufacturing process.

StockTwits

Trading The News: Eleven Biotherapeutics In The News